eugenelabs logo Back to condition list

Glutaric acidemia type II (ETFDH-related)

Glutaric acidemia type II (GAII) causes the body to have difficulty breaking down proteins and fats, causing them to build up in the blood and other tissues.

The seriousness of the condition varies from person to person, with some people being mildly affected and others having more severe symptoms. Symptoms usually begin in infancy and early childhood and include low blood sugar, poor muscle tone, and failure to grow and gain weight normally. Some affected children also have problems with their heart, brain, liver or kidneys.

Those with a serious form of GAII may die in early childhood, whilst those with a milder case may only develop symptoms later in life and during periods of stress or illness.

Quick facts about glutaric acidemia type II (ETFDH-related)
Genes: ETFDH
Inheritance: Autosomal Recessive
Alternative Names: GAII
Relevant resources for glutaric acidemia type II (ETFDH-related)

A quick genetics rundown

As humans we have about 23,000 genes. These genes are like tiny instruction manuals that influence our health, growth and development. We inherit half of our genes from our biological mum and the other half from our biological dad. These genes are lined up on structures called chromosomes. Most of us have 23 pairs of chromosomes. The first 22 pairs are called autosomes and for the most part - these are the same among men and women. The 23rd pair determine our sex - two X chromosomes for a female and one X and one Y chromosome for males.

Learn more about genetics

How is glutaric acidemia type II (ETFDH-related) inherited?

glutaric acidemia type II (ETFDH-related) is known as an autosomal recessive condition. For autosomal recessive conditions, if a person has a variation in one copy of their gene, they are a carrier. This means that they are healthy because they also have a working copy of the gene. But, they can still pass their non-working copy to their child.

If the other parent also happens to be a carrier of the same gene, there is a 25% (1 in 4) chance that they both pass this gene variation on to their child — and as such, have a child affected by the condition.

If both parents are carriers of glutaric acidemia type II (ETFDH-related), there's a one in four chance that their children could develop symptoms.

What is carrier screening?

Carrier testing is like a checkup for your genes. It tests to see if you carry a gene variation that could cause a serious genetic condition in your child. Eugene offers an inclusive genetic carrier screening panel that includes glutaric acidemia type II (ETFDH-related), but there's a total 301 conditions that can be tested.

Eugene's carrier test is a clinical grade test that can be done from the comfort of your own home — it's just a saliva test. You're also paired with a genetic counsellor who provides mindful support and guidance every step of the way.

Learn more about carrier screening

Should parents screen for glutaric acidemia type II (ETFDH-related) before or early in pregnancy?

The biggest benefit of screening for glutaric acidemia type II (ETFDH-related) is that it can help future parents understand their reproductive risk so they can be ready and empowered to make more informed decisions. If neither partner are carriers, it provides reassurance and peace of mind that the risk of having a child with a genetic condition is low.

Since 90% of children that have a recessive genetic condition like glutaric acidemia type II (ETFDH-related) had no previous family history of it, it often feels completely out of the blue for the parents. Getting screened is a way to know this risk in advance, which can help familes manage or even prevent the condition in the first place.